Individuals who do not complete followup colonoscopy after a positive stool test could be at substantially higher risk for ...
Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...
At-home FIT screening involves testing stool for amounts of blood too small to see, which can help to diagnose colon cancer ...
Please provide your email address to receive an email when new articles are posted on . The multitarget stool DNA test had a positive predictive value of 31.4% for detecting advanced adenomas.
Colorectal cancer (CRC) is the second most common cause of cancer death in the United States and disproportionally impacts people who receive care in under-resourced settings.
Emerging diagnostic tools like the GI-MAP stool test and breath-based microbiome analysis are expanding options for detecting gut health issues. These methods offer targeted insights into microbial ...
Stool-based DNA testing can help bridge CRC screening gaps between rural and urban populations by providing timely follow-up. The study found no significant difference in follow-up times for ...
A pragmatic cluster-randomized trial across 8 CHC sites (Boston and Los Angeles) enrolled 5127 adults aged 45–75 years ...
October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...
These are the FDA-approved options to test for prostate, colorectal, and cervical cancer.
ORLANDO -- Patients with inflammatory bowel disease (IBD) reported mostly favorable responses with the use of mail-order kits for stool sample collections, according to a survey study. Among survey ...
A fecal fat test measures the amount of fat in a person’s stool. The test assesses the digestive function and absorption of fat in the gastrointestinal tract. Several medical conditions cause poor fat ...